The Current Ratio as of December 2025 (TTM) for Abbisko Cayman Limited (2256.HK) is 11.59

According to Abbisko Cayman Limited’s latest financial reports and current stock price. The company's current Current Ratio is 11.59. This represents a change of -12.53% compared to the average of 13.26 of the last 4 quarters.

Abbisko Cayman Limited (2256.HK) Historical Current Ratio (quarterly & annually)

How has 2256.HK Current Ratio performed in the past?

The mean historical Current Ratio of Abbisko Cayman Limited over the last ten years is 21.41. The current 11.59 Current Ratio has changed 5.31% with respect to the historical average. Over the past ten years (40 quarters), 2256.HK's Current Ratio was at its highest in in the March 2021 quarter at 35.91. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Abbisko Cayman Limited (2256.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Abbisko Cayman Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abbisko Cayman Limited (2256.HK) Average Current Ratio

How has 2256.HK Current Ratio performed in the past?

The current Current Ratio of Abbisko Cayman Limited (2256.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Abbisko Cayman Limited (2256.HK) Current Ratio vs. Peers

How is 2256.HK’s Current Ratio compared to its peers?

Abbisko Cayman Limited’s Current Ratio is greater than CARsgen Therapeutics Holdings Limited (6.45), greater than Alphamab Oncology (4.98), greater than HBM Holdings Limited (6.05), less than Ascletis Pharma Inc. (14.57), greater than CStone Pharmaceuticals (1.44), less than Nanjing Leads Biolabs Co Ltd (0), greater than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (1.89), greater than IVD Medical Holding Limited (1.79), greater than CK Life Sciences Int'l., (Holdings) Inc. (1.49), greater than Lepu Biopharma Co., Ltd. (0.63),

Build a custom stock screener for Abbisko Cayman Limited (2256.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abbisko Cayman Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abbisko Cayman Limited (2256.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abbisko Cayman Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.